Joseph Michael Fitzgerald - 13 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP & Group Pres, Cardiology
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
13 Feb 2025
Transactions value $
-$621,062
Form type
4
Filing time
18 Feb 2025, 17:52:06 UTC
Previous filing
14 Feb 2025
Next filing
21 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +4.36K +2.5% $0.00 179K 14 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability -$211K -1.99K -1.11% $106.11 177K 14 Feb 2025 Direct
transaction BSX Common Stock Options Exercise $0 +3.96K +2.24% $0.00 181K 16 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability -$192K -1.81K -1% $106.11 179K 16 Feb 2025 Direct
transaction BSX Common Stock Options Exercise $0 +4.17K +2.32% $0.00 183K 17 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability -$218K -2.06K -1.12% $106.11 181K 17 Feb 2025 Direct
holding BSX Common Stock 4.89K 13 Feb 2025 By Child F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +11.2K $0.00 11.2K 13 Feb 2025 Common Stock 11.2K Direct F1, F3
transaction BSX Stock Option (Right to Buy) Award $0 +28.8K $0.00 28.8K 13 Feb 2025 Common Stock 28.8K $106.14 Direct F4
transaction BSX Restricted Stock Units Options Exercise $0 -4.36K -33.33% $0.00 8.73K 14 Feb 2025 Common Stock 4.36K Direct F1, F5
transaction BSX Restricted Stock Units Options Exercise $0 -3.96K -50% $0.00 3.96K 16 Feb 2025 Common Stock 3.96K Direct F1, F6
transaction BSX Restricted Stock Units Options Exercise $0 -4.17K -100% $0.00 0 17 Feb 2025 Common Stock 4.17K Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F4 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F6 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F7 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.